Huang, Fei

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

Talpaz, M., Shah, N. P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., Cortes, J., O'Brien, S., Nicaise, C., Bleickardt, E., et al. (2006) · New England Journal of Medicine

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 1,760

Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection

Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., & Clark, E. (2007) · Cancer Research

Breast Cancer Treatment StudiesCancer Mechanisms and Therapy

Cited by 344

DNA Damage Activates TGF-β Signaling via ATM-c-Cbl-Mediated Stabilization of the Type II Receptor TβRII

Li, Y., Liu, Y., Chiang, Y. J., Huang, F., Li, Y., Li, X., Ning, Y., Zhang, W., Deng, H., & Chen, Y.-G. (2019) · Cell Reports

TGF-β signaling in diseasesDNA Repair Mechanisms

Cited by 61

Correlation between Gene Expression of IGF-1R Pathway Markers and Cetuximab Benefit in Metastatic Colorectal Cancer

Huang, F., Xu, L.-A., & Khambata-Ford, S. (2012) · Clinical Cancer Research

Colorectal Cancer Treatments and StudiesGrowth Hormone and Insulin-like Growth Factors

Cited by 33

High Levels of BMP2 Promote Liver Cancer Growth via the Activation of Myeloid-Derived Suppressor Cells

Wu, G., Huang, F., Chen, Y., Zhuang, Y., Huang, Y., & Xie, Y. (2020) · Frontiers in Oncology

Immune cells in cancerTGF-β signaling in diseases

Cited by 22